biomark002.449 - General Sample Prep Header


Biotage Joins the Swedish GeneNova Collaboration for Gene Therapy Drugs

Aug 30, 2022 12:52:16 PM / by Biotage

Funded by academia, Vinnova and industry, a five-year multi-disciplinary collaboration has been launched to improve efficiency in production methods for adeno-associated virus (AAV) based gene therapies. Biotage is contributing with technology and expertise in plasmid DNA and AAV purification, as well as by funding a dedicated PhD student within the project. “We are thrilled to join the GeneNova project to develop transformative improvements of the drug development and production processes for gene therapies.” says Tomas Blomquist, President and CEO of Biotage.

Read the press release here.




Written by Biotage

Learn From Future Blog Posts